Exact Sciences Corporation (EXAS) Revenue by Segment
Exact Sciences revenue by segment at a glance
In Q3 fiscal 2025 (the quarter ended September 30, 2025), Exact Sciences's largest product or service was Screening, with $666.24 million or 78% of revenue, up 22.3% from a year earlier. Next: Precision Oncology (22%).
By region, United States brought in 93% and Non-US brought in 7% of revenue in Q3 fiscal 2025.
By country, UNITED STATES brought in 93% and Non-US brought in 7% of revenue in Q3 fiscal 2025.
The fastest-growing product or service from a year earlier was Screening (+22.3%).
From company filings, in USD; latest quarter ended September 30, 2025; quarterly data from Q4 fiscal 2018.
Exact Sciences Corporation
Revenue breakdown
Fiscal quarters, from company filings
Exact Sciences revenue by product or service, last 4 quarters
| Product or service | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Share |
|---|---|---|---|---|---|
| Screening | $666.2M | $628.5M | $540.0M | $544.9M | 78% |
| Precision Oncology | $184.5M | $182.6M | $166.8M | $163.8M | 22% |
In USD, fiscal quarters as reported; share = part of Q3 FY25 revenue.
Exact Sciences revenue by region, last 4 quarters
| Region | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Share |
|---|---|---|---|---|---|
| United States | $792.0M | $755.8M | $655.2M | $659.2M | 93% |
| Non-US | $58.8M | $55.3M | $51.6M | $49.4M | 7% |
In USD, fiscal quarters as reported; share = part of Q3 FY25 revenue.
Exact Sciences revenue by country, last 4 quarters
| Country | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Share |
|---|---|---|---|---|---|
| UNITED STATES | $792.0M | $755.8M | $655.2M | $659.2M | 93% |
| Non-US | $58.8M | $55.3M | $51.6M | $49.4M | 7% |
In USD, fiscal quarters as reported; share = part of Q3 FY25 revenue.
Questions and answers
Which product or service makes the most money for Exact Sciences?
Screening: $666.24 million, or 78% of revenue, in Q3 fiscal 2025.
What are Exact Sciences's main products and services?
By revenue in Q3 fiscal 2025: Screening (78%) and Precision Oncology (22%).
Where does Exact Sciences make its money?
By region in Q3 fiscal 2025: United States (93%) and Non-US (7%).
